Mutation analysis of ovarian carcinoma patients presenting optimal response to neoadjuvant chemotherapy

被引:0
|
作者
Rouleau, Etienne [1 ]
dos Santos, Elizabeth Santana [2 ]
Maela, Francilette [1 ]
Lacroix, Ludovic [1 ]
Auguste, Aurelie [1 ]
Pautier, Patricia [1 ]
Morice, Philippe [1 ]
Genestie, Catherine [1 ]
Leary, Alexandra [1 ]
机构
[1] Inst Gustave Rousy, Villejuif, France
[2] AC Camargo Canc Ctr, Sao Paulo, Brazil
关键词
D O I
10.1158/1538-7445.SABCS18-3504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3504
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy for Patients with advanced epithelial ovarian cancer: A Meta-Analysis
    Zeng, Long-Jia
    Xiang, Chun-Lin
    Gong, Yi-Zhen
    Kuang, Yan
    Lu, Fang-Fang
    Yi, Su-Yi
    Zhang, Yue
    Liao, Meng
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Assessment of the response in patients with colorectal carcinoma treated with neoadjuvant chemotherapy by PET and CT
    Ribelles, M.
    Arredondo, J.
    Prieto, E.
    Sancho, L.
    Garcia-Velloso, M.
    Hernandez, J.
    Richter, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S474 - S474
  • [43] Does Apoptotic Index Predict the Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma?
    Askan, Gokce
    Okcu, Oguzhan
    Ozturk, Cigdem
    Ozturk, Seda Duman
    Sen, Bayram
    Bedir, Recep
    MEDENIYET MEDICAL JOURNAL, 2023, 38 (01):
  • [44] Neoadjuvant chemotherapy for Patients with advanced epithelial ovarian cancer: A Meta-Analysis
    Long-Jia Zeng
    Chun-Lin Xiang
    Yi-Zhen Gong
    Yan Kuang
    Fang-Fang Lu
    Su-Yi Yi
    Yue Zhang
    Meng Liao
    Scientific Reports, 6
  • [45] THE EFFECT OF SURGICAL DEBULKING ON THE RESPONSE OF PATIENTS WITH OVARIAN-CARCINOMA TO CHEMOTHERAPY
    MCDERMOTT, DF
    JAFFE, EA
    COLEMAN, M
    PASMANTIER, MW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 520 - 523
  • [46] CA125 NORMALIZATION FOLLOWING NEOADJUVANT CHEMOTHERAPY COMPLEMENTING THE CHEMOTHERAPY RESPONSE SYSTEM IN THE PROGNOSTICATION OF PATIENTS WITH HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Li, J.
    Wu, M.
    Wang, L.
    Lin, Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A164 - A164
  • [47] Chemotherapy response ccore (CRS) combined with clinical characteristics predict prognosis in high-grade serous ovarian carcinoma (HGSOC) patients with neoadjuvant chemotherapy
    Xu, Qin
    Liu, Jing
    Pan, Junping
    Song, Yanwen
    Luo, Lan
    Hu, Dan
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S185 - S185
  • [48] CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy
    Bregar, Amy
    Mojtahed, Amirkasra
    Kilcoyne, Aoife
    Kurra, Vikram
    Melamed, Alexander
    Growdon, Whitfield
    Rauh-Hain, J. Alejandro
    del Carmen, Marcela
    Lee, Susanna, I
    GYNECOLOGIC ONCOLOGY, 2019, 152 (03) : 568 - 573
  • [49] Neoadjuvant chemotherapy in advanced ovarian cancer: what is the optimal number of cycles?
    Ltaief, Sarra Ben
    Bouhani, Malek
    Houissa, Iness
    Sakhri, Saida
    Bouaziz, Hanen
    Dhiab, Tarek Ben
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A200 - A200
  • [50] NEOADJUVANT CHEMOTHERAPY MAY IMPAIR RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN CANCER PATIENTS
    Ekmann-Gade, A. W.
    Hogdall, C.
    Peen, U. B. S.
    Engelholm, S. A.
    Fago-Olsen, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 675 - 676